We do not support your browser. Please take a moment and upgrade to the most recent version of Internet Explorer.

Catalyzing Innovation in Late Phase Clinical Trial Design and Statistical Analysis Plans Resource Access
Deadline: October 19, 2018 05:00 PM

This deadline has passed and is no longer active

The purpose of this FOA is to provide access to a consultative resource for planning activities for late phase (phase II and beyond) single-site or multi-site investigator-initiated clinical trials that address critical clinical questions within the mission of the National Heart, Lung, and Blood Institute (NHLBI) and that require non-traditional clinical trial designs with the opportunity for statistical novelty and/or innovation. The FOA will support the development of feasible and well-designed clinical trials utilizing consultative services provided by the Innovative Clinical Trials Resource (ICTR) (N01).

Note: X01 Clinical Trials not allowed.

Read the full FOA:  PAR-18-768

Return to Deadline Listings